Restorative Therapies, Inc., Receives FDA Clearance for RT300 Enhancements

Share Article

Restorative Therapies, Inc., a designer and supplier of medical devices, today announced FDA clearance of new RT50 wireless stimulator modules and core muscle stimulation for its breakthrough medical device, the RT300, a functional electrical stimulation (FES) motorized ergometer system.

RT300 leg and arm system

The ability to stimulate the core muscles is unique; strengthening these core muscles in conjunction with the upper or lower limbs provides increased neuromuscular activation improving the opportunities for better outcomes.

Restorative Therapies, Inc., a designer and supplier of medical devices, today announced FDA clearance of new RT50 wireless stimulator modules and core muscle stimulation for its breakthrough medical device, the RT300, a functional electrical stimulation (FES) motorized ergometer system.

In the treatment of neurological damage, FES is used to evoke motor functions to previously paralyzed muscles. The RT300 delivers electrical currents to activate muscles in the arms and legs, enabling paralyzed legs to move through a regular patterned physical activity. The system is designed for both home and clinic use.

Up to four RT50 wireless stimulator modules can be now be added to an RT300 FES system. This means that up to 10 muscle groups can be electrically stimulated during a single therapy session. The range of muscles that can be selected for stimulation has also been increased to include the core muscles - abdominal and erector spinae (back) muscles. These core muscles can be stimulated while either leg or arm cycling with the RT300 system.

"The new RT50 wireless stimulators make the RT300 system even more efficient." says Associate Professor Susan Harkema of the University of Louisville and the Frazier Rehabilitation Institute in Louisville, Kentucky. "The ability to stimulate the core muscles is unique; strengthening these core muscles in conjunction with the upper or lower limbs provides increased neuromuscular activation improving the opportunities for better outcomes." Harkema concludes.

"These latest enhancements to the RT300 system make it a truly flexible FES cycling system" says Andrew Barriskill, CEO of Restorative Therapies. "Therapists can select any of the major muscle groups for stimulation while their patient works with the ergometer. All of the therapy data continues to be logged to the RT300's Internet database"

For further details please contact Judy Kline, 800 609-9166.

About Restorative Therapies, Inc.
Restorative Therapies, is a privately-held company headquartered in Baltimore, Md., whose mission is to help people with neurological impairment achieve their full recovery potential. Restorative Therapies is one of the first companies to target activity-based therapy and FES as a treatment for immobility associated with paralysis such as stroke, cerebral palsy, multiple sclerosis and spinal cord injury.

Restorative Therapies is now also marketing the RT300 directly into Australia and Canada. Distributors have been appointed in several other key markets.

About Prof. Susan Harkema
Susan Harkema, PhD, is the Associate Professor and Rehabilitation Research Director of the Kentucky Spinal Cord Injury Research Center at the Department of Neurological Surgery, University of Louisville.

Prof. Harkema's primary research aim is to understand neural mechanisms responsible for human locomotion and the level of plasticity after neurologic injury. Prof. Harkema's studies emphasize the importance of basic neural principles of locomotion that are applicable to all animals. The results of her studies contribute to the knowledge about the fundamental mechanisms of control of human locomotion and may provide strategies than can be used by physical therapists for the rehabilitation of walking for patients after neurologic injury.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

JUDY KLINE
Visit website